We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
While Antiplatelets Are Good…They Aren’t for Everyone
Valeria Caso, MD, PhD
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
W. Brian Gibler, MD, FACEP, FACC, FAHA
Rhonda Cadena, MD, FNCS, FCCM
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
Preventing Ischemic Stroke in Today’s World
Mike Sharma, MD, MSc, FRCPC
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Greg Albers, MD
Stroke Management of the Future? The Potential Role of Factor XI/XIa Inhibitors in Secondary Stroke Prevention
Manesh R. Patel, MD
Ashkan Shoamanesh, MD
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Emerging Data in the Management of Acute Ischemic Stroke/TIA
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
Natalie Kreitzer, MD, MS
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
Patient-Centric Approaches to Managing Migraines in the Female Patient
Jessica Ailani, MD
Dawn C. Buse, PhD
Do Women Respond Differently to ATT Than Men?
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
What Does ARIA Look Like Clinically?
Which Amyloid-Targeting Therapy is Best?
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy
Which Biomarkers Do You Recommend to Confirm Amyloid Positivity?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education